NCT04978324

Brief Summary

The purpose of this research study is to find out about the effect of growth factors extracted from blood on improving healing of periodontal pockets (Gum pockets) after deep gum cleaning.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2022

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 16, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 27, 2021

Completed
9 months until next milestone

Study Start

First participant enrolled

May 1, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

May 12, 2022

Status Verified

May 1, 2022

Enrollment Period

7 months

First QC Date

July 16, 2021

Last Update Submit

May 6, 2022

Conditions

Outcome Measures

Primary Outcomes (5)

  • Change in probing depths (PD)

    PD will be measured from the gingival margin to pocket base using a participant specific fabricated removable resin stent with an assigned #15 UNC probe.

    Baseline to 6 months

  • Change in clinical attachment level (CAL)

    CAL will be measured from cemento-enamel junction CEJ to the base of the pocket using the same stent as PD

    Baseline to 6 months

  • Bleeding on probing (BOP)

    Bleeding on probing (BOP) will be recorded on an ordinal scale where sites that will bleed on probing will be given a score of 1 while sites that don't bleed will be given a score of 0.

    Baseline to 6 months

  • Plaque index (PI)

    PI will be recorded using the Loe and Silness Index. Scores range from 0 - No plaque to 3 - Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin.

    Baseline to 6 months

  • Gingival index

    GI will be recorded using the Loe and Silness gingival index. Scores range from 0 - Normal gingiva to 3 - Severe inflammation - marked redness and edema, ulceration. Tendency toward spontaneous bleeding.

    Baseline to 6 months

Study Arms (2)

Autogenous Growth Factors Left Side

EXPERIMENTAL

5-8mm pockets on the left side of the mouth will receive insertion of small treatment after deep cleaning. The right side of the mouth will receive deep cleaning only, the standard of care.

Biological: leukocyte platelet rich fibrin (L-PRF)Procedure: Scaling and Root Planing

Autogenous Growth Factors Right Side

EXPERIMENTAL

5-8mm pockets on the right side of the mouth will receive insertion of small treatment after deep cleaning. The left side of the mouth will receive deep cleaning only, the standard of care.

Biological: leukocyte platelet rich fibrin (L-PRF)Procedure: Scaling and Root Planing

Interventions

Participants blood will be spun to obtain L-PRF strips and liquid L-PRF. Pockets will receive insertion of small L-PRF strips followed by liquid L-PRF injections to fill the 5-8mm pockets of the test side.

Autogenous Growth Factors Left SideAutogenous Growth Factors Right Side

Scaling and root planing, which is the standard of care, will be performed on the control side using Cavitron and hand scalers on test and control sides under local anesthesia.

Autogenous Growth Factors Left SideAutogenous Growth Factors Right Side

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Systemically healthy (ASA 1 or 2) adults over the age of 18
  • A similar number of bilateral 5-8 mm pocket depths
  • Diagnosed with Stage II or Stage III chronic periodontitis.

You may not qualify if:

  • Uncontrolled systemic illness that may affect healing or clotting such as diabetes mellitus, immunocompromisation, bleeding disorders, ongoing chemo- or radiotherapy
  • Active smokers
  • Pregnancy
  • Periodontal treatment in the last six months
  • Antibiotic therapy within three months prior to treatment
  • Taking medications that could affect periodontal status or healing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Virginia Commonwealth University

Richmond, Virginia, 23298, United States

Location

MeSH Terms

Interventions

Tooth ExfoliationRoot Planing

Intervention Hierarchy (Ancestors)

Dental Physiological PhenomenaDigestive System and Oral Physiological PhenomenaDental ScalingDental ProphylaxisPeriodonticsDentistrySubgingival CurettagePreventive Dentistry

Study Officials

  • Thomas Waldrop, DDS

    Virginia Commonwealth University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 16, 2021

First Posted

July 27, 2021

Study Start

May 1, 2022

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

May 12, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations